Related references
Note: Only part of the references are listed.EFFECT OF CHRONIC ASPIRIN ADMINISTRATION ON AN EXPERIMENTAL MODEL OF METABOLIC SYNDROME
Nicolas F. Renna et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2009)
The immune response in atherosclerosis: a double-edged sword
Goran K. Hansson et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Cytokines in atherosclerosis: Pathogenic and regulatory pathways
A Tedgui et al.
PHYSIOLOGICAL REVIEWS (2006)
Cytokines affecting endothelial and smooth muscle cells in vascular disease
EW Raines et al.
JOURNAL OF LIPID RESEARCH (2005)
Vascular smooth muscle cell NAD(P)H oxidase activity during the development of hypertension: Effect of angiotensin II and role of insulinlike growth factor-1 receptor transactivation
MC Cruzado et al.
AMERICAN JOURNAL OF HYPERTENSION (2005)
STATs as critical mediators of signal transduction and transcription: lessons learned from STAT5
K Paukku et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2004)
Synthesis of immune modulators by smooth muscles
CA Singer et al.
BIOESSAYS (2004)
Interleukins in atherosclerosis:: Molecular pathways and therapeutic potential
JH von der Thüsen et al.
PHARMACOLOGICAL REVIEWS (2003)
Early changes in proteoglycans production by resistance arteries smooth muscle cells of hypertensive rats
N Risler et al.
AMERICAN JOURNAL OF HYPERTENSION (2002)
Anti-inflammatory mechanisms in the vascular wall
A Tedgui et al.
CIRCULATION RESEARCH (2001)
Essential hypertension Part I: Definition and etiology
OA Carretero et al.
CIRCULATION (2000)
Share Paper
